{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:49:50Z","timestamp":1746712190840,"version":"3.40.5"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:p>The Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics recommend routine screening for pregnant women for evidence of infection with human immunodeficiency virus, hepatitis B and syphilis, and vaginal-rectal colonization with group B Streptococcus. For each of these pathogens, there are important opportunities to provide maternal treatment, prevent vertical transmission of the pathogen during the prenatal or intrapartum periods, and\/or administer neonatal treatment immediately after birth. Such prevention and\/or treatment measures are critical to limiting maternal and neonatal morbidity; however, this is dependent on recognition of maternal disease status. A significant number of women in the United States receive either inadequate prenatal care or inadequate screening for these pathogens. The time of admission to labor and delivery units represents an important opportunity to detect at-risk pregnant women and infants. To optimize both maternal and neonatal health, the Joint Commission issued new guidance effective July 1, 2018, mandating documentation of maternal disease status for these pathogens in the maternal medical record and documentation of positive results in the newborn medical record. Immediate peripartum testing for women with inadequate screening is also required. These measures should allow for timely interventions to improve maternal health and ideally to prevent perinatal disease transmission to the newborn.<\/jats:p>","DOI":"10.1542\/neo.20-10-e584","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T13:25:18Z","timestamp":1569936318000},"page":"e584-e591","source":"Crossref","is-referenced-by-count":1,"title":["Update on Prenatal Laboratory Screening: Joint Commission Required Elements"],"prefix":"10.1542","volume":"20","author":[{"given":"Jared L.","family":"Tepper","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Puopolo","sequence":"additional","affiliation":[{"name":"Section on Newborn Medicine, Pennsylvania Hospital, Philadelphia, PA"},{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"issue":"3","key":"2021121007322100300_B1","first-page":"1","article-title":"Timing and adequacy of prenatal care in the United States, 2016","volume":"67","author":"Osterman","year":"2018","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"2021121007322100300_B2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s10995-013-1289-7","article-title":"Factors associated with human immunodeficiency virus screening of women during pregnancy, labor and delivery, United States, 2005-2006","volume":"18","author":"Fitz Harris","year":"2014","journal-title":"Matern Child Health J"},{"issue":"7","key":"2021121007322100300_B3","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1097\/INF.0000000000001516","article-title":"Hepatitis B surface antigen testing among pregnant women, United States 2014","volume":"36","author":"Kolasa","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2021121007322100300_B4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/OLQ.0000000000000569","article-title":"Suboptimal prenatal syphilis testing among commercially insured women in the United States, 2013","volume":"44","author":"Neblett Fanfair","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2021121007322100300_B5","unstructured":"The Joint Commission. Maternal infectious disease status assessment and documentation standards for hospitals and critical access hospitals: R3 report\u2014requirement, rationale, reference. Available at: https:\/\/www.jointcommission.org\/r3_issue_12\/. Accessed July 2, 2019"},{"key":"2021121007322100300_B6","volume-title":"Guidelines for Perinatal Care","author":"Kilpatrick","year":"2017","edition":"8th ed"},{"issue":"4","key":"2021121007322100300_B7","article-title":"Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 dependent areas, 2016","volume":"23","author":"Centers for Disease Control and Prevention","year":"2018","journal-title":"HIV Surveillance Suppl Rep"},{"issue":"3","key":"2021121007322100300_B8","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/AOG.0000000000002825","article-title":"ACOG committee opinion no. 752: prenatal and perinatal human immunodeficiency virus infection testing","volume":"132","author":"Committee on Obstetric Practice","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021121007322100300_B9","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1097\/AOG.0000000000002820","article-title":"ACOG committee opinion no. 751: labor and delivery management of women with human immunodeficiency virus infection","volume":"132","author":"Committee on Obstetric Practice","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021121007322100300_B10","doi-asserted-by":"crossref","first-page":"e20171870","DOI":"10.1542\/peds.2017-1870","article-title":"Elimination of perinatal hepatitis B: providing the first vaccine dose within 24 hours of birth","volume":"140","author":"Committee on Infectious Diseases","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007322100300_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"2021121007322100300_B12","doi-asserted-by":"crossref","first-page":"e1141","DOI":"10.1542\/peds.2014-3213","article-title":"Outcomes of infants born to women infected with hepatitis B","volume":"135","author":"Schillie","year":"2015","journal-title":"Pediatrics"},{"key":"2021121007322100300_B13","unstructured":"Centers for Disease Control and Prevention. Screening pregnant women for hepatitis B virus (HBV) infection. Available at: https:\/\/www.cdc.gov\/hepatitis\/hbv\/pdfs\/PrenatalHBsAgTesting.pdf. Accessed August 2, 2019"},{"issue":"1","key":"2021121007322100300_B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"issue":"24","key":"2021121007322100300_B15","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121007322100300_B16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","article-title":"#38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission","volume":"214","author":"Dionne-Odom","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2021121007322100300_B17","doi-asserted-by":"crossref","first-page":"e20162013","DOI":"10.1542\/peds.2016-2013","article-title":"Epidemiology of invasive early-onset neonatal sepsis, 2005-2014","volume":"138","author":"Schrag","year":"2016","journal-title":"Pediatrics"},{"key":"2021121007322100300_B18","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/cid\/cix660","article-title":"Maternal disease with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021121007322100300_B19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/AOG.0b013e318280d4f6","article-title":"Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease","volume":"121","author":"Fairlie","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2021121007322100300_B20","doi-asserted-by":"crossref","first-page":"e20182894","DOI":"10.1542\/peds.2018-2894","article-title":"Management of neonates born at \u226535 0\/7 weeks\u2019 gestation with suspected or proven early-onset bacterial sepsis","volume":"142","author":"Puopolo","year":"2018","journal-title":"Pediatrics"},{"issue":"1","key":"2021121007322100300_B21","first-page":"e19","article-title":"Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion No. 782","volume":"134","year":"2019","journal-title":". Obstet Gynecol"},{"issue":"2","key":"2021121007322100300_B22","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1881","article-title":"Committee on Fetus and Newborn; Committee on Infectious Diseases. Management of infants at risk for group B streptococcal disease","volume":"144","author":"Puopolo","year":"2019","journal-title":"Pediatrics"},{"key":"2021121007322100300_B23","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance: Bact Facts Interactive. Available at: https:\/\/wwwn.cdc.gov\/BactFacts\/index.html. Accessed July 2, 2019"},{"issue":"2","key":"2021121007322100300_B24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"2021121007322100300_B25","first-page":"773","article-title":"Syphilis","volume-title":"Red Book: 2018 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2018"},{"key":"2021121007322100300_B26","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/20\/10\/e584\/821701\/neoreviews_062019rev00098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/20\/10\/e584\/821701\/neoreviews_062019rev00098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T18:54:29Z","timestamp":1639162469000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/20\/10\/e584\/91999\/Update-on-Prenatal-Laboratory-Screening-Joint"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.20-10-e584","relation":{},"ISSN":["1526-9906"],"issn-type":[{"type":"electronic","value":"1526-9906"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}